WGS GeneDx Holdings Corp. - Class A Common Stock
$42.00
Price · May 20, 2026
52W Range
$32–$171
7% of range
Analyst Rating
BUY
13 analysts
Price Target
$77
+83% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
WGS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$42.00
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$32 – $171
WGS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
WGS
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
WGS
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
WGS
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
WGS
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
WGS
Peer Median
WGS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
13 analysts
- Strong Buy 4 30.8%
- Buy 8 61.5%
- Hold 1 7.7%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
9 analysts · 2026-05-18
Median
$75.00
← Below all targets
$42.00
Low
$50.00
High
$100.00
Median target
$75.00
+78.6%
Mean target
$77.00
+83.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.09%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.28 | $-0.01 | -0.27% |
| Dec. 31, 2025 | $0.14 | $0.11 | 0.03% |
| Sept. 30, 2025 | $0.49 | $0.43 | 0.06% |
| June 30, 2025 | $0.50 | $0.10 | 0.40% |
| March 31, 2025 | $0.27 | $0.06 | 0.21% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| WGS | — | — | — | — | — | — |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| PNTG | $975M | 33.5 | 36.3% | 3.1% | 8.4% | — |
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AMN | $606M | -6.4 | -8.5% | -3.5% | -15.3% | 28.3% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.